www.industry-asia-pacific.com
11
'18
Written on Modified on
Asco
Emerson Demonstrates at Analytica how ASCO Microfluidic Valve Customers can Shorten Product Development Cycles
Emerson will be in Hall A1, Stand 213. Customers can learn about the 2-day sample programme for ASCO Microfluidic valves as well as how they can reduce the cost of reagents in Clinical Diagnostic Applications.

As well as being able to discuss the 2 day sample programme, Emerson will be displaying their microfluidic valves used in clinical diagnostic applications. These valves are designed to withstand some of the industry’s harshest chemicals. A key benefit of the ASCO microfluidic isolation valves is their ultra-low dead volume, which reduces the consumption of costly detective reagents. The use of chemically-inert materials makes them suitable for a wide range of applications.
Another key feature of the microfluidic isolation valve range is their extremely low power consumption. The advent of Point of Care testing, means that instrument power budgets are critical to a project design team, something Emerson have taken into account, as they offer some of the lowest power coils in the industry.
Emerson’s expert engineers will be on hand to do discuss the demands of you project throughout the event and you can also find out how to receive products from the ASCO standard portfolio, including the micro-fluidic isolation valves, as a sample at just two days notice.
For more information about Analytica 2018, visit asco.com